NCT03702608 - BIONICS 38 mm Trial EluNIR Ridaforolimus Eluting Coronary Stent System (EluNIR) In Coronary Stenosis Trial | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 14, 2018

Primary Completion Date

March 1, 2019

Study Completion Date

April 30, 2020

Conditions

Coronary Stenosis

Interventions

COMBINATION_PRODUCT

EluNIR Ridaforolimus Eluting Coronary Stent System

"The EluNIR Ridaforolimus Eluting Coronary Stent System is a single use device/drug combination product comprising of:~* Stent - a mounted Cobalt Chromium (CoCr) alloy based stent - 38 mm length and 2.75mm, 3.0 mm, 3.5mm, 4.0mm diameter~* Delivery System - Rapid Exchange (RX) Coronary System~* Polymer matrix coating - (PBMA) and CarboSil®~* Ridaforolimus drug"

Trial Locations (1)

Unknown

Medinol LTD, Tel Aviv